Korean J Ophthalmol.  2004 Jun;18(1):15-22. 10.3341/kjo.2004.18.1.15.

Ganglion Cell Death in Rat Retinaby Persistent Intraocular Pressure Elevation

Affiliations
  • 1Department of Ophthalmology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 2Department of Anatomy, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

Glaucoma is characterized by loss of retinal ganglion cells (RGCs) and their axons. Retrograde axoplasmic transport blockade and excitotoxicity were proposed to be a major cause of RGC apoptosis. We conducted this study to characterize the episcleral vessel cauterization glaucoma model in the rat with respect to decreased retrograde axoplasmic flow and subsequent apoptotic RGC death. After episcleral vessels were cauterized in Sprague-Dawley rats, Fluorogold was injected into their superior colliculi by stereotactic method. Retrograde axoplasmic flow and TUNEL-stained apoptotic dead cells were observed microscopically. Elevated intraocular pressure was maintained for up to 6 weeks during follow-up. Retrograde axoplasmic flow to the rat retina was significantly decreased. Apoptotic RGC was selectively TUNELstained in the retina, especially at the ganglion cell layers. We concluded that elevated intraocular pressure caused apoptotic RGC death through retrograde axoplasmic flow blockage. Further studies will elucidate the neuroprotection strategies in glaucoma patients.

Keyword

apoptosis; glaucoma; retinal ganglion cell

MeSH Terms

Animals
*Apoptosis
Axonal Transport
Disease Models, Animal
In Situ Nick-End Labeling
*Intraocular Pressure
Male
Ocular Hypertension/*complications
Rats
Rats, Sprague-Dawley
Retinal Ganglion Cells/*pathology
Retrograde Degeneration/etiology
Sclera/blood supply

Figure

  • Fig. 1 Retinal ganglion cells (RGCs) in the control and cauterized eyes with chronic, moderately elevated IOP were labeled with Fluorogold. Fluorogold was microinjected into the superior colliculi of anesthetized rats in a stereotaxic apparatus (Stereotactic, Stoelting, USA). Retrograde axoplasmic flow to the RGCs decreased due to blockage.

  • Fig. 2 Bar histogram representing mean densities (cell/ unit area) of fluorogold labeled retinal ganglion cells (RGCs) for the experimental retina. Densities were significantly decreased for 6 weeks. Error bar represents the standard deviation.

  • Fig. 3 TUNEL negative retinal ganglion cells (RGCs) in control eyes (A) and positive RGCs in the cauterized eyes (B-F) are visualized by confocal microscopy, Whole-mount( A-E, ×200, F. ×400). The TUNEL reaction preferentially labels DNA strand breaks generated during apoptosis. An RGC neuron with condensed chromatin clumping in the nucleus is shown. This allows discrimination of apoptosis from necrosis.

  • Fig. 4 TUNEL negative retinal ganglion cells (RGCs) in control eyes (A) and positive RGCs in the cauterized eyes (B-D) are seen; cross section. TUNEL labeling detects DNA fragments indicative of cellular apoptosis. Fluorescent apoptotic dead cells are shown chiefly on ganglion cell layers during postoperative 6 weeks.


Reference

1. Morrison JC, Fraunfelder FW, Milne ST, Moore CG. Limbal microvasculature of the rat eye. Invest Ophthalmol Vis Sci. 1995. 36:751–756.
2. Valenzuela EG, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995. 61:33–44.
3. Sawada A, Neufeld AH. Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res. 1999. 69:525–531.
4. Johnson EC, Deppmeier LM, Wentzien SK, Wentzien SK, Hsu I, Morrison JC. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthalmol Vis Sci. 2000. 41:431–432.
5. Jia L, Cepurna WO, Johnson EC, Morrison JC. Patterns of intraocular pressure elevation after aqueous humor outflow obstruction in rats. Invest Ophthalmol Vis Sci. 2000. 41:1380–1385.
6. Mittag TW, Danias J, Pohorenec G, Yuan HM, Burakgazi E, Redman RC, Pods SM, Tatton WG. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2000. 41:3451–3459.
7. Bayer AU, Danias J, Brodie S, Maag KP, Chen B, Shen F, Podos SM, Mittag TW. Electroretinographic abnormalities in a rat glaucoma model with chronic elevated intraocular pressure. Exp Eye Res. 2001. 72:667–677.
8. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995. 36:774–786.
9. Quigley HA, Mckinnon SJ, Zack DJ, Pease ME, Baumrind LA, Kerrigan FK, Mitchell RS. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci. 2000. 41:3460–3466.
10. Ko ML, Hu DN, Ritch R, Sharma SC. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000. 41:2967–2971.
11. Goldblum D, Mittag T. Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye. Vision Res. 2002. 42:471–478.
12. Levkovitch-Verbin H, Quigley HA, Keith R, Martin KR, Valenta D, Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci. 2002. 43:402–410.
13. Morgan JE. Retinal ganglion cell shrinkage in glaucoma. J Glaucoma. 2002. 11:365–370.
14. Tatton NA, Tezel Z, Insolia SA, Nandor SA, Edward PD, Wax MB. In situ detection of apoptosis in normal pressure glaucoma: preliminary examination. Surv Ophthalmol. 2001. 45:S268–S272.
15. Wang X, Tay SS, Ng YK. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp Brain Res. 2000. 476–484.
16. Wein FB, Levin LA. Current understanding of neuroprotection in glaucoma. Curr Opin Ophthalmol. 2002. 13:61–67.
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr